Insmed saw some selling pressure today and moved down -4.86%
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Insmed hasn't shown a lot of strength recently, shareholders don't seem that energized about the Biotechnology company's future prospects. INSM might find some support at the 105.01 level, buyers might push the price back up from here. But it's not very clear what will happen.
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 96 | -3.31844 | -3.70042 | -11.9873 | -8.79667 | 8.50552 | 13.0743 | 38.0313 | 13.6739 | 13.1664 | 18.4108 | -14319.4 | -12365.8 | 2.8646 | 29.4271 | 6.94002 | 1.13521 |
| Healthcare | 225 | -2.49529 | -2.66444 | -6.36978 | -0.324445 | 16.079 | 18.06 | 42.6533 | 17.22 | 11.5058 | 12.1394 | -12056 | -11010.5 | 4.2222 | 19.4444 | 5.3921 | 0.768844 |